BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

April 18, 2000

View Archived Issues

Sanofi-Synthelabo begins rolling out Xatral XL in Europe

Read More

Kosan Biosciences awarded SBIR grant to develop motilin receptor agonists

Read More

Maxygen to acquire ProFound Pharma

Read More

Atrix to be issued broader U.S. patent for BEMA technology

Read More

Isis Pharmaceuticals completes financing with Elan for HCV joint venture

Read More

EC-1007: a novel antitumor compound produced by Trichocladium

Read More

UCLA describes novel antimicrobial peptides

Read More

Novel approach to cell-targeted therapy of HIV designed by Lepetit

Read More

Celecoxib: use in inflammatory conditions of the head and neck

Read More

Trials demonstrate efficacy, safety and freedom from dependency for novel narcolepsy therapy

Read More

Retinamide with superior potency to fenretinide identified by NCI, M.D. Anderson Cancer Center

Read More

Subjects with sleep apnea being recruited for multicenter study

Read More

Alkylating anthraquinone maintains activity against resistant ovarian cancer cells

Read More

Corixa receives U.S. patent on RA vaccine

Read More

Antex Biologics makes progress in traveler's diarrhea vaccine

Read More

Karolinska Institute and Bristol-Myers Squibb sign cancer pharmacogenomics collaboration

Read More

Activella receives U.S. approval for postmenopausal osteoporosis prevention

Read More

IGT Pharma adds to neuropharmaceutical patent filings

Read More

CPMP recommends approval of Myocet in Europe

Read More

FDA approves Mobic for osteoarthritis symptom relief

Read More

Patent issued to University of Rochester, setting off heated debate over rights to COX-2 inhibitors

Read More

Yakult Honsha profiles novel ACAT inhibitor at major national industry meeting

Read More

Tolterodine emerges triumphant from long-term studies supporting the drug as "gold standard"

Read More

Promising new treatment approach to gastric cancer involves a modified herpesvirus

Read More

Lilly and Ono to collaborate on ARDS therapeutic

Read More

U.S. academics discover potential gene therapy for restenosis

Read More

Panorama studies CC-1065 analogues with improved anticancer activity, safety

Read More

News from FASEB: PST-2744 is a promising treatment for heart failure

Read More

Dainippon describes motility-enhancing activity of 5-HT4 receptor agonists

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 10, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing